                               SEQUENCE LISTING

<110> GILEAD SCIENCES, INC.
 
<120> COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS

<130> 1349-WO-PCT

<140> PCT/US2021/047800
<141> 2021-08-26

<150> 63/215,310
<151> 2021-06-25

<150> 63/162,283
<151> 2021-03-17

<150> 63/071,134
<151> 2020-08-27

<160> 5     

<170> PatentIn version 3.5

<210> 1
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1
Arg Arg Cys Pro Leu Tyr Ile Ser Tyr Asp Pro Val Cys Arg Arg 
1               5                   10                  15  


<210> 2
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 2
Arg Arg Arg Arg Cys Pro Leu Tyr Ile Ser Tyr Asp Pro Val Cys Arg 
1               5                   10                  15      


Arg Arg Arg 
            


<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 3
ttacaaacat tggccgcaaa                                                   20


<210> 4
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 4
gcgcgacatt ccgaagaa                                                     18


<210> 5
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      probe"

<400> 5
acaatttgcc cccagcgctt cag                                               23


